1. Home
  2. NNDM vs IFRX Comparison

NNDM vs IFRX Comparison

Compare NNDM & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.56

Market Cap

322.1M

Sector

Technology

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$2.18

Market Cap

303.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
IFRX
Founded
2012
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
322.1M
303.4M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
NNDM
IFRX
Price
$1.56
$2.18
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
1.7M
945.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$102,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
77.30
N/A
52 Week Low
$1.19
$0.80
52 Week High
$2.32
$2.95

Technical Indicators

Market Signals
Indicator
NNDM
IFRX
Relative Strength Index (RSI) 47.91 54.28
Support Level $1.48 $0.87
Resistance Level $1.58 $2.57
Average True Range (ATR) 0.05 0.18
MACD -0.00 -0.01
Stochastic Oscillator 34.85 37.39

Price Performance

Historical Comparison
NNDM
IFRX

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.

About IFRX InflaRx N.V.

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: